Xianglin ShiPrincipal Scientist at Biogen
Xianglin Shi received a B.S. in chemistry from Yanan University and a M.S. from Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences. He obtained his Ph.D. from Emory University under the direction of Prof. Lanny S. Liebeskind. As a process chemist, he worked at Rhodia Chirex, Millennium Pharmaceuticals, and Biogen and was involved in process R&D, scale-up, and manufacturing. In his most recent roles in Biogen, he is responsible for oligonucleotide chemical process development including solid-supported and solution-phase synthesis, and involved in process validation, manufacturing, and worldwide regulatory filing including Spinraza.